Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

CHRONIC RENAL FAILURE IN OLD AGE IN PRIMARY- DIAGNOSED PATIENTS MULTIPLE MYELOMA IG A IMMUNOCHEMICAL OPTION

Baratova M.A. 1 Baratova D.A. 2
1 AO «Republican Scientific Center of Emergency Medical Assistance»
2 NMU «Eurasian Center oncohematology
The article presents the clinical and laboratory parameters of patients with multiple myeloma and kirghiz ethnic Russian population of Kirghizia, where at primary diagnosis is carefully analyzed serum creatinine, serum calcium, increased frequency of titer immunoglobulin A. Given that the disease is detected in the elderly given us studies have shown that the primary diagnosis most often manifestations of chronic renal failure among patients registered MM kirghiz ethnic group compared to patients with MM-speaking population of Kirghizia. This comparative characteristic for the first time in a study on the incidence of Ig A-myeloma with chronic renal failure in patients with MM and kirghiz ethnic Russian population of Kirghizia. Based on test results Ig A-myeloma among kirghiz population is more common. At the early stage of the disease in patients with MM stage II immunochemical variant Ig A-myeloma kirghiz nationality, revealed chronic renal failure and often contributes to the rapid progression of the disease and less favorable outcome. Chronic renal failure - one of the main clinical and laboratory signs of MM, combined with low survival, therefore it is necessary to use all sorts of ways to prevent the progression of chronic renal failure, including active treatment of urinary tract infections and selection of therapy. With timely diagnosis of Ig A myeloma and chronic renal failure to improve survival at the present stage requires the use of high-dose chemotherapy followed by an indication of scheduling a bone marrow transplant. Bone marrow transplantation is not dependent on the patient’s age in myeloma with chronic renal failure gives the best results.